The Import Tariffs of Bosnia and Herzegovina are harmonized each year with the Combined Nomenclature of EU and legislative regulations.
In addition to the formal approval and oversight processes, the pharmaceutical regulations in Bosnia and Herzegovina also include provisions for post-market surveillance, which is vital for monitoring the performance of drugs after they have been released into the market.
Taxation in Bosnia and Herzegovina includes both federal and local taxes. Tax revenue in Bosnia and Herzegovina stood at 28.6% of GDP in 2013. Most important revenue sources include the income tax, Social Security contributions, corporate tax, and the value added tax, which are all applied on the federal level.
The drug approval process in Bosnia and Herzegovina is a comprehensive system that ensures the safety, efficacy, and quality of pharmaceutical products available to the public.
Prices of medicines are formed by adding distribution and retail margin, and value added tax (VAT). We have conducted analysis on factors affecting prices and suggested possible action to reduce prices.
View Details
IRP had impact on price decrease for top 10 cardiovascular medicines in B&H, especially in a first two years of implementation. From the third year after IRP implementation, there were no significant
View Details
Prices of medicines are formed by adding distribution and retail margin, and value added tax (VAT). We have conducted analysis on factors afecting prices and suggested possible action to reduce prices.
View Details
When importing goods from Bosnia and Herzegovina subject to the 30% tariff rate, businesses must ensure proper compliance with customs regulations.
View Details
The data from the official documents of Bosnia and Herzegovina relating to the price of drugs on reimbursement lists from certain regions in Bosnia and Herzegovina, spanning the period
View Details
Explore the intricate landscape of pharmaceutical regulations in Bosnia and Herzegovina, highlighting the roles of key regulatory authorities, the comprehensive drug approval process, and
View Details
The World Bank has urged the authorities in Bosnia and Herzegovina to implement regulations on the pricing of medicines that were initially approved more than three years ago, but
View Details
The Import Tariffs of Bosnia and Herzegovina are harmonized each year with the Combined Nomenclature of EU and legislative regulations.
View Details
For years, citizens of Bosnia and Herzegovina have been paying the most expensive medicines in the region in relation to their standard of living. The main reasons are the unregulated
View DetailsPDF version includes complete article with source references. Suitable for printing and offline reading.
